Pilot Study to Evaluate the Effect of Mabthera [rituximab] in Combination With MTX [methotrexate] in the Inhibition of Progression of Synovitis, Bone Marrow Edema, and Erosions Evaluated by Magnetic Resonance Imaging (MRI) in the Hand of Patients With Rheumatoid Arthritis.
Phase of Trial: Phase IV
Latest Information Update: 18 Aug 2017
At a glance
- Drugs Rituximab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Roche
- 31 Aug 2018 Biomarkers information updated
- 18 May 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
- 18 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.